J.P. Morgan analyst Benjamin Rossi maintained a Buy rating on Tenet Healthcare yesterday and set a price target of $260.00. The company’s shares closed yesterday at $173.78.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to TipRanks, Rossi is an analyst with an average return of -4.0% and a 43.75% success rate. Rossi covers the Healthcare sector, focusing on stocks such as Universal Health, US Physical Therapy, and Tenet Healthcare.
Currently, the analyst consensus on Tenet Healthcare is a Strong Buy with an average price target of $246.93, which is a 42.09% upside from current levels. In a report released on May 14, Bank of America Securities also maintained a Buy rating on the stock with a $230.00 price target.
Based on Tenet Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $5.37 billion and a net profit of $702 million. In comparison, last year the company earned a revenue of $5.22 billion and had a net profit of $406 million
